Suppression of the morphine-induced rewarding effect in the rat with neuropathic pain: implication of the reduction in mu-opioid receptor functions in the ventral tegmental area - PubMed (original) (raw)

Suppression of the morphine-induced rewarding effect in the rat with neuropathic pain: implication of the reduction in mu-opioid receptor functions in the ventral tegmental area

Satoru Ozaki et al. J Neurochem. 2002 Sep.

Abstract

The present study was designed to investigate the rewarding effect, G-protein activation and dopamine (DA) release following partial sciatic nerve ligation in the rat. Here we show for the first time that morphine failed to produce a place preference in rats with nerve injury. Various studies provide arguments to support that the mesolimbic dopaminergic system, which projects from the ventral tegmental area (VTA) to the nucleus accumbens (N.Acc), is critical of the motivational effects of opioids. In the present study, there were no significant differences between sham-operated and sciatic nerve-ligated rats in the increases in guanosine-5'-o-(3-[35S]thio)triphosphate ([35S]GTPgammaS) binding to membranes of the N.Acc stimulated by either DA, the D1 receptor agonist SKF81297, the D2 receptor agonist N-propylnoraporphine or the D3 receptor agonist 7-hydroxy-2-dipropylaminotetralin (7-OH DPAT). In contrast, the increases in [35S]GTPgammaS binding to membranes of the VTA induced by either morphine or a selective micro -opioid receptor agonist [d-Ala2, NMePhe4, Gly(ol)5]enkephalin were significantly attenuated in nerve-ligated rats as compared with sham- operated rats. Furthermore, the enhancement of DA release in the N.Acc stimulated by morphine was significantly suppressed by sciatic nerve ligation. These findings suggest that attenuation of the morphine-induced place preference under neuropathic pain may result from a decrease in the morphine-induced DA release in the N.Acc with reduction in the mu-opioid receptor-mediated G-protein activation in the VTA.

PubMed Disclaimer

Cited by

Inflammatory Pain Promotes Increased Opioid Self-Administration: Role of Dysregulated Ventral Tegmental Area μ Opioid Receptors.
Hipólito L, Wilson-Poe A, Campos-Jurado Y, Zhong E, Gonzalez-Romero J, Virag L, Whittington R, Comer SD, Carlton SM, Walker BM, Bruchas MR, Morón JA. Hipólito L, et al. J Neurosci. 2015 Sep 2;35(35):12217-31. doi: 10.1523/JNEUROSCI.1053-15.2015. J Neurosci. 2015. PMID: 26338332 Free PMC article.
Kappa Opioid Signaling at the Crossroads of Chronic Pain and Opioid Addiction.
Cahill CM, Lueptow L, Kim H, Shusharla R, Bishop A, Evans CJ. Cahill CM, et al. Handb Exp Pharmacol. 2022;271:315-350. doi: 10.1007/164_2021_434. Handb Exp Pharmacol. 2022. PMID: 33547588 Free PMC article.
Opioid facilitation of rewarding electrical brain stimulation is suppressed in rats with neuropathic pain.
Ewan EE, Martin TJ. Ewan EE, et al. Anesthesiology. 2011 Mar;114(3):624-32. doi: 10.1097/ALN.0b013e31820a4edb. Anesthesiology. 2011. PMID: 21293250 Free PMC article.
The response to rapid infusion of fentanyl in the human brain measured using pulsed arterial spin labelling.
Zelaya FO, Zois E, Muller-Pollard C, Lythgoe DJ, Lee S, Andrews C, Smart T, Conrod P, Vennart W, Williams SC, Mehta MA, Reed LJ. Zelaya FO, et al. MAGMA. 2012 Apr;25(2):163-75. doi: 10.1007/s10334-011-0293-4. Epub 2011 Nov 24. MAGMA. 2012. PMID: 22113518
[Chronic pain : Perception, reward and neural processing].
Becker S, Diers M. Becker S, et al. Schmerz. 2016 Oct;30(5):395-406. doi: 10.1007/s00482-016-0149-y. Schmerz. 2016. PMID: 27576865 Review. German.

Suppression of the morphine-induced rewarding effect in the rat with neuropathic pain: implication of the reduction in mu-opioid receptor functions in the ventral tegmental area - PubMed (original) (raw)